Page last updated: 2024-09-04

cilomilast and l-826,141

cilomilast has been researched along with l-826,141 in 2 studies

Compound Research Comparison

Studies
(cilomilast)
Trials
(cilomilast)
Recent Studies (post-2010)
(cilomilast)
Studies
(l-826,141)
Trials
(l-826,141)
Recent Studies (post-2010) (l-826,141)
1621342710

Protein Interaction Comparison

ProteinTaxonomycilomilast (IC50)l-826,141 (IC50)
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)0.0055
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.0024

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blouin, M; Brideau, C; Chauret, N; Ducharme, Y; Frenette, R; Friesen, RW; Girard, Y; Hamel, P; Jones, TR; Laliberté, F; Li, C; Masson, P; McAuliffe, M1
Jabaris, SS; Kodimuthali, A; Pal, M1

Reviews

1 review(s) available for cilomilast and l-826,141

ArticleYear
Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.
    Journal of medicinal chemistry, 2008, Sep-25, Volume: 51, Issue:18

    Topics: Asthma; Humans; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive

2008

Other Studies

1 other study(ies) available for cilomilast and l-826,141

ArticleYear
Substituted 4-(2,2-diphenylethyl)pyridine-N-oxides as phosphodiesterase-4 inhibitors: SAR study directed toward the improvement of pharmacokinetic parameters.
    Bioorganic & medicinal chemistry letters, 2002, Oct-21, Volume: 12, Issue:20

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Alkylation; Animals; Biological Availability; Cell Line; Cyclic Nucleotide Phosphodiesterases, Type 4; Half-Life; Humans; Indicators and Reagents; Phosphodiesterase Inhibitors; Pyridines; Rats; Structure-Activity Relationship; Tumor Necrosis Factor-alpha

2002